A venture capital and private equity firm investing in pharmaceutical and healthcare companies.
As of December 2019, Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs TechnologiesGenelabs Technologies, and Chelsea Therapeutics International.